PDF(Pubmed)
Abstract：
The growth of the transgender and/or gender diverse (TGD) community has created an increased demand for comprehensive and evidence-based gender-affirming care, especially when providing a hormone-based regimen. Although there are known risks of adverse events from receiving exogenous hormone replacement therapy, many of these risks are typically attributed to members of the TGD community receiving estrogen-based therapy. In this report, a case of a subsegmental pulmonary embolism in a male patient assigned female at birth who was actively receiving testosterone-based, female-to-male gender-affirming care is detailed. In doing so, attention is drawn to a potential complication of this approach, thereby empowering clinicians and patients alike to be cognizant of such risks while still pursuing this otherwise pivotal and necessary care.
摘要：
变性人和/或性别多样化（TGD）社区的增长增加了对全面和基于证据的性别确认护理的需求，特别是当提供基于激素的方案时。尽管已知接受外源性激素替代疗法会有不良事件的风险，这些风险中的许多通常归因于接受雌激素治疗的TGD社区成员.在这份报告中,一例在出生时分配给女性的男性患者中出现亚段肺栓塞，该患者积极接受基于睾丸激素的治疗，详细介绍了女性对男性的性别确认护理。在这样做的时候，注意这种方法的潜在复杂性，从而使临床医生和患者都能够认识到这种风险，同时仍然追求这种关键和必要的护理。
